Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > NEXT NEWS
View:
Post by alnova on Dec 14, 2021 1:33am

NEXT NEWS

I hope I'm wrong, but I expect with a JP Morgan event coming soon, the next news from Sernova will be that Dr. T is presenting. And the share price will suffer once again.
Comment by MustangSalley on Dec 14, 2021 9:43am
Well, a new VP of Investors Relations . Funny they don't mention name of healthcare company he worked for 23 years . Giving options away like candy 1.3 million dsu's. I wonder if Chris knows that there is a shadow IR VP that has great influence in the name of Ray Matthews ? Why is Ray Matthews still around and how many dsu is he getting ? Nothing on the 7 th patient ?  Nothing ...more  
Comment by BioTeck on Dec 14, 2021 10:46am
LOL another IR guy? When is spillup going to learn? Never obviously. How many is that now? Are we at 10 failed and costly attempts at IR now? What a joke, only thing left now for him to do is release news about another presentation and get that share price back to 1.20 where it belongs. All the IR in the world won't help this CEO.
Comment by Mercuryfilling1 on Dec 14, 2021 11:23am
https://ca.linkedin.com/in/christopher-barnes-18700b15 ...the missing link(edin)? Hmmm.
Sernova Corp